vs
INDEPENDENCE REALTY TRUST, INC.（IRT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是INDEPENDENCE REALTY TRUST, INC.的1.3倍（$219.9M vs $165.3M），INDEPENDENCE REALTY TRUST, INC.同比增速更快（2.5% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 2.2%）
独立房地产信托是一家专注于商业地产领域的不动产投资信托企业，投资布局覆盖费城、华盛顿特区以及得克萨斯州奥斯汀市的优质写字楼资产，为投资者创造稳定的不动产投资回报。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
IRT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.3倍
$165.3M
营收增速更快
IRT
高出0.6%
2.0%
两年增速更快
OFIX
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $165.3M | $219.9M |
| 净利润 | — | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | — | 0.2% |
| 净利率 | — | -1.0% |
| 营收同比 | 2.5% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $0.00 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRTOFIX
| Q1 26 | $165.3M | — | ||
| Q4 25 | $167.1M | $219.9M | ||
| Q3 25 | $167.1M | $205.6M | ||
| Q2 25 | $162.2M | $203.1M | ||
| Q1 25 | $161.2M | $193.6M | ||
| Q4 24 | $161.0M | $215.7M | ||
| Q3 24 | $160.1M | $196.6M | ||
| Q2 24 | $158.4M | $198.6M |
净利润IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | $33.3M | $-2.2M | ||
| Q3 25 | $6.9M | $-22.8M | ||
| Q2 25 | $8.0M | $-14.1M | ||
| Q1 25 | $8.4M | $-53.1M | ||
| Q4 24 | $-1.0M | $-29.1M | ||
| Q3 24 | $12.4M | $-27.4M | ||
| Q2 24 | $10.4M | $-33.4M |
毛利率IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | -8.3% | ||
| Q2 25 | — | -7.9% | ||
| Q1 25 | — | -25.2% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | — | -9.6% | ||
| Q2 24 | — | -12.5% |
净利率IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | 19.9% | -1.0% | ||
| Q3 25 | 4.1% | -11.1% | ||
| Q2 25 | 5.0% | -6.9% | ||
| Q1 25 | 5.2% | -27.4% | ||
| Q4 24 | -0.6% | -13.5% | ||
| Q3 24 | 7.7% | -13.9% | ||
| Q2 24 | 6.5% | -16.8% |
每股收益（稀释后）IRTOFIX
| Q1 26 | $0.00 | — | ||
| Q4 25 | $0.14 | $-0.05 | ||
| Q3 25 | $0.03 | $-0.57 | ||
| Q2 25 | $0.03 | $-0.36 | ||
| Q1 25 | $0.04 | $-1.35 | ||
| Q4 24 | $-0.01 | $-0.76 | ||
| Q3 24 | $0.05 | $-0.71 | ||
| Q2 24 | $0.05 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.3M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.4B | $450.0M |
| 总资产 | $6.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRTOFIX
| Q1 26 | $23.3M | — | ||
| Q4 25 | $23.6M | $82.0M | ||
| Q3 25 | $23.3M | $62.9M | ||
| Q2 25 | $19.5M | $65.6M | ||
| Q1 25 | $29.1M | $58.0M | ||
| Q4 24 | $21.2M | $83.2M | ||
| Q3 24 | $17.6M | $30.1M | ||
| Q2 24 | $21.0M | $26.4M |
总债务IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $157.2M | ||
| Q2 25 | $2.2B | $157.0M | ||
| Q1 25 | $2.3B | $156.9M | ||
| Q4 24 | $2.3B | $157.0M | ||
| Q3 24 | $2.3B | $118.5M | ||
| Q2 24 | $2.3B | $118.0M |
股东权益IRTOFIX
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | $450.0M | ||
| Q3 25 | $3.5B | $442.5M | ||
| Q2 25 | $3.4B | $458.3M | ||
| Q1 25 | $3.5B | $458.3M | ||
| Q4 24 | $3.4B | $503.1M | ||
| Q3 24 | $3.4B | $525.9M | ||
| Q2 24 | $3.4B | $546.0M |
总资产IRTOFIX
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.0B | $850.6M | ||
| Q3 25 | $6.1B | $832.6M | ||
| Q2 25 | $6.0B | $837.2M | ||
| Q1 25 | $6.0B | $823.1M | ||
| Q4 24 | $6.1B | $893.3M | ||
| Q3 24 | $5.9B | $867.9M | ||
| Q2 24 | $5.9B | $882.0M |
负债/权益比IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.66× | 0.36× | ||
| Q2 25 | 0.66× | 0.34× | ||
| Q1 25 | 0.65× | 0.34× | ||
| Q4 24 | 0.68× | 0.31× | ||
| Q3 24 | 0.68× | 0.23× | ||
| Q2 24 | 0.66× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | $282.1M | $27.7M | ||
| Q3 25 | $79.3M | $12.4M | ||
| Q2 25 | $82.2M | $11.6M | ||
| Q1 25 | $60.4M | $-18.4M | ||
| Q4 24 | $259.8M | $23.7M | ||
| Q3 24 | $69.2M | $11.7M | ||
| Q2 24 | $83.0M | $9.0M |
自由现金流IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K |
自由现金流率IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% |
资本支出强度IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% |
现金转化率IRTOFIX
| Q1 26 | — | — | ||
| Q4 25 | 8.48× | — | ||
| Q3 25 | 11.51× | — | ||
| Q2 25 | 10.22× | — | ||
| Q1 25 | 7.23× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.60× | — | ||
| Q2 24 | 8.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRT
| Rental and other property revenue | $165.2M | 100% |
| Other revenue | $109.0K | 0% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
